OPIOID WITHDRAWAL

Clinical trials for OPIOID WITHDRAWAL explained in plain language.

Never miss a new study

Get alerted when new OPIOID WITHDRAWAL trials appear

Sign up with your email to follow new studies for OPIOID WITHDRAWAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New sublingual drug aims to make opioid withdrawal less painful

Symptom relief Ongoing

This study tests a new sublingual film (BXCL501) containing dexmedetomidine, a non-opioid drug, to reduce withdrawal symptoms in people with opioid use disorder. About 160 adults who are physically dependent on opioids will receive BXCL501, lofexidine, or a placebo during a 7-day…

Matched conditions: OPIOID WITHDRAWAL

Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief

Last updated May 11, 2026 20:46 UTC

OPIOID WITHDRAWAL

Get alerted when new OPIOID WITHDRAWAL trials appear

New sublingual drug aims to make opioid withdrawal less painful